Project Grant R21AI196700
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University $593,021.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 20, 2025, for a project period extending through May 31, 2030. This Project Grant supports mechanistic investigation of rotavirus non-structural protein 6 (NSP6), an auxiliary protein that counters host immune defense mechanisms. The research deliverables include...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $481,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 16, 2025 through June 30, 2027. The award supports research investigating human rotavirus egress and infection in association with extracellular vesicles (EVs)—membrane-bound structures released from cells that can transport viral...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $458,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 4, 2025, with completion targeted for August 31, 2027. The project focuses on developing and advancing a VP4-based pseudovirus nanoparticle (S-VP4E) rotavirus vaccine for oral immunization. Rotavirus causes severe...
- Federal Project Grant Award Summary Baylor College of Medicine received a $454,288 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The award funds research investigating the immune function of the RNA helicase DDX6, specifically examining how this protein regulates hematopoietic stem cell (HSC) maintenance, quiescence, and immune...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $348,615 to the Research Foundation of The City University of New York (RFCUNY) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from May 1, 2026, through April 30, 2028. The award funds investigator-initiated biomedical research designed to characterize how rotaviruses exploit extracellular vesicles (EVs) for non-lytic intercellular...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $502,248 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 6, 2025, with completion targeted for May 31, 2030. This research initiative focuses on investigating the STING (Stimulator of Interferon Genes) pathway's role in protecting human intestinal epithelial cells from rotavirus infection. The project will...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $653,742 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 7, 2026, with completion targeted for March 31, 2031. The award supports research to elucidate the molecular mechanisms of maternal antibody interference with oral rotavirus vaccination, a critical barrier to vaccine efficacy...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $2,920,356 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period September 1, 2025, through August 31, 2029. This award funds research investigating the role of norovirus capsid dynamics in adaptive immune evasion. The project will utilize the mouse norovirus (MNV) model system to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Methodist Hospital Research Institute a Project Grant of $444,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, with a completion date of July 31, 2027. This research project will characterize a previously unknown intercellular signaling pathway in Group B Streptococcus (GBS) and determine its contribution to bacterial pathogenesis. Specifically,...
- Federal Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 8, 2025, with a completion date of July 31, 2027. The grant funds development and validation of a novel TC-24 Enzyme-Linked Immunosorbent Assay (ELISA) test to evaluate post-treatment efficacy for Chagas disease, a neglected tropical disease endemic...
Baylor College of Medicine received a $240,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2028. The award supports research aimed at understanding rotavirus pathogenesis mechanisms and vaccine development. Specifically, the funded research defines the structural and functional characteristics of particle-associated rotavirus nonstructural protein 4 (NSP4), a critical viral protein required for triple-layered particle assembly and infectivity. The project characterizes NSP4 domains that interact with viral spike proteins and cellular integrins, providing foundational knowledge to advance rotavirus vaccine efficacy and combat a pathogen responsible for over 200,000 annual deaths globally, particularly in low-income countries. The research deliverables include molecular characterization studies, immunological analysis, and structural-functional analysis of NSP4's role in viral assembly and host cell receptor interactions. These investigations generate scientific knowledge and methodological advances intended to improve vaccine design strategies against rotavirus infections, directly supporting the Allergy and Infectious Diseases Research program's objective of establishing and expanding biomedical research addressing infectious diseases and related health challenges.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $240.0k | 4/1/26 |